We serve Zinc Picolinate CAS:17949-65-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Product name: Zinc Picolinate
CAS No.: 17949-65-4
Molecular Formula:C12H8N2O4Zn
Molecular Weight: 309.59
Characters: white crystal with good hygroscopicity, easily soluble in water.
Specifications:
| Zinc Picolinate | Export Pharmaceutical grade | Feed grade |
| Item | Spec. | Spec. |
| Assay % | ≥99 | ≥98.5 |
| Zinc % | 20.0-21.0 | 20.0-21.0 |
| Heav metal(as Pb) % | ≤0.001 | ≤0.002 |
| As% | ≤0.0005 | ≤0.0005 |
| Sulphates % | ≤0.2 | ≤0.2 |
| Drying loss % | ≤2.0 | ≤2.0 |
| Fineness(40 meshes sieve) % | ≥95 | ≥95 |
Product Usage: pharmaceutical intermediate, feed additives.
Packaging: 25kg cardboard drum, lined with double-layer plastic bag
Storage Precautions: Stored in cool, draughty and dry place at room temperature.
Contact us for information like Cuprous chloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Zinc Pyridine-2-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Cupric hydroxide Use and application,Zinc Picolinate technical grade,usp/ep/jp grade.
Related News: Drug manufacturers make medicines by mixing APIs and pharmaceutical excipients.Hydroxytyrosol manufacturer The Philippines, the United States and Australia have expanded travel restrictions, temporarily barring noncitizens who have recently traveled to China.dibenzofuran-4,6-bis-(boronic acid) supplier Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.1-bromo-7-fluoroheptane vendor Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.
